A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

Clinical trial NCT02210689 · COMPLETED

Trial details

NCT number: NCT02210689
Sponsor: Actavis Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

BACTERIAL VAGINOSIS Signs and Symptoms to be Evaluated and Recorded Include Vaginal Discharge Color, Odor, and Consistency Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

Start date: 2014-01-01
Primary completion: 2014-10-01
Enrollment: 604

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.